Sex Differences in the Clinical Presentation and Natural History of Dilated Cardiomyopathy

Ruth Owen, Rachel Buchan, Michael Frenneaux, Julian W.E. Jarman, Resham Baruah, Amrit S. Lota, Brian P. Halliday, Angharad M. Roberts, Cemil Izgi, Harriette G.C. Van Spall, Erin D. Michos, John J.V. McMurray, James L. Januzzi, Dudley J. Pennell, Stuart A. Cook, James S. Ware, Paul J. Barton, John Gregson, Sanjay K. Prasad, Upasana Tayal

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Biological sex has a diverse impact on the cardiovascular system. Its influence on dilated cardiomyopathy (DCM) remains unresolved. Objectives: This study aims to investigate sex-specific differences in DCM presentation, natural history, and prognostic factors. Methods: The authors conducted a prospective observational cohort study of DCM patients assessing baseline characteristics, cardiac magnetic resonance imaging, biomarkers, and genotype. The composite outcome was cardiovascular mortality or major heart failure (HF) events. Results: Overall, 206 females and 398 males with DCM were followed for a median of 3.9 years. At baseline, female patients had higher left ventricular ejection fraction, smaller left ventricular volumes, less prevalent mid-wall myocardial fibrosis (23% vs 42%), and lower high-sensitivity cardiac troponin I than males (all P < 0.05) with no difference in time from diagnosis, age at enrollment, N-terminal pro–B-type natriuretic peptide levels, pathogenic DCM genetic variants, myocardial fibrosis extent, or medications used for HF. Despite a more favorable profile, the risk of the primary outcome at 2 years was higher in females than males (8.6% vs 4.4%, adjusted HR: 3.14; 95% CI: 1.55-6.35; P = 0.001). Between 2 and 5 years, the effect of sex as a prognostic modifier attenuated. Age, mid-wall myocardial fibrosis, left ventricular ejection fraction, left atrial volume, N-terminal pro–B-type natriuretic peptide, high-sensitivity cardiac troponin I, left bundle branch block, and NYHA functional class were not sex-specific prognostic factors. Conclusions: The authors identified a novel paradox in prognosis for females with DCM. Female DCM patients have a paradoxical early increase in major HF events despite less prevalent myocardial fibrosis and a milder phenotype at presentation. Future studies should interrogate the mechanistic basis for these sex differences.

Original languageEnglish (US)
Pages (from-to)352-363
Number of pages12
JournalJACC: Heart Failure
Volume12
Issue number2
DOIs
StatePublished - Feb 2024

Keywords

  • females
  • heart
  • males
  • sex

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Sex Differences in the Clinical Presentation and Natural History of Dilated Cardiomyopathy'. Together they form a unique fingerprint.

Cite this